Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clam-Tone
- Development stage
- Unknown
- Lead developer
- Greenlife Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Clam-Tone is an oral calcium supplement developed and marketed by Greenlife Pharmaceuticals, a Nigerian pharmaceutical company. Formulated as a tablet, it is primarily indicated for building and maintaining strong teeth and bones across all age groups. As a generic small molecule product, it provides essential calcium, a critical mineral for bone mineralization, dental health, and various physiological processes including muscle contraction and nerve transmission. The product is categorized as a vitamin and multivitamin supplement within Greenlife's portfolio and is an approved, marketed product in Nigeria.
- Brand names
- Clam-Tone
- Other names
- Clam-Tone Tablet
Beyond the preview
Go deeper on Clam-Tone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Clam-Tone.